Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. extrulub

ExtruLub

Commercialisation of Advanced Extrusion Technologies Delivering Disruptive Innovation for the Next Generation of Catheter Based Medical Devices.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 ExtruLub project word cloud

Explore the words cloud of the ExtruLub project. It provides you a very rough idea of what is the project "ExtruLub" about.

site    reducing    polymer    core    protective    extrulub    initial    generation    antimicrobial    manufacturer    2020    revenue    line    profile    realise    23    replace    international    device    customers    ambition    whilst    full    preferred    safety    science    170mn    business    cardiology    alternatives    safeguarding    facilitates    market    ca    demonstrated    sub    30    model    customer    51    innovative    3mn    original    5bn    564mn    42    grow    realising    jobs    13    resins    combined    savings    attaining    surfaces    15    urology    extrusion    generate    advancing    perspective    globally    manufacturing    sits    drugs    functional    economic    harnessing    markets    skilled    global    anti    hollister    batch    containment    medtronic    applicable    reduce    catheter    21    share    boston    lean    differentiation    margins    materials    showed    diania    company    gross    scientific    oems    friction    mn    coloplast    engineering    world    assists    function    measured    enhancement    alone    genuine    eg    first    thrombogenic    equating    technologies    gain    patient    surface    independent    chemistry    disruptive    oem    command    supply    medical   

Project "ExtruLub" data sheet

The following table provides information about the project.

Coordinator		 DIANIA TECHNOLOGIES LIMITED 

Organization address
address: UNIT 120 NUIG BUSINESS INNOVATION CENTRE UPPER NEWCASTLE
city: GALWAY
postcode: H91 Y682
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Ireland [IE]
 Project website http://linkedin.com/company/DiaNia-Technologies
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DIANIA TECHNOLOGIES LIMITED IE (GALWAY) coordinator 50˙000.00

Map

 Project objective

ExtruLub is an innovative, disruptive extrusion technology applicable across a range of medical polymer resins, which has the ability to change the surface of a catheter without affecting core device properties. The technology sits in the component sub-supply global market with an initial value of €564mn applicable across all catheter markets (combined value of $42.5bn globally by 2020). From a functional perspective, ExtruLub has the ability to reduce surface friction, generate protective antimicrobial & anti-thrombogenic surfaces & deliver site specific drugs all whilst reducing catheter profile. This enhancement of catheter function assists in safeguarding patient safety & will command genuine product differentiation for the original equipment manufacturer (OEM) of the end device, enabling them to gain market share.From an economic perspective it facilitates a change from lean to batch manufacturing realising cost containment for the target customer.Taking the cardiology sector as an example, an independent study demonstrated ExtruLub would reduce costs for the OEM (eg Boston Scientific, Medtronic etc.) by 51% realising savings of ca. €3mn p.a in one product. In the urology sector, the measured impact showed increased gross margins of ca.13% on one product line alone enabling €21.5 mn p.a. savings for potential customers like Hollister, Coloplast etc. DiaNia Technologies ambition is to grow into a world leading, international technology company, realising market share through disruptive technologies.Our initial goal is to replace current ExtruLub alternatives attaining a 30% market share with the friction product, equating to €170mn in full production.Harnessing advanced polymer chemistry through materials science and engineering has the potential to realise €23.3mn in revenue & 15 new, highly skilled jobs within the first 4 years through a business model preferred by OEMs.This disruptive technology is the key to advancing the next generation of medical devices.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EXTRULUB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EXTRULUB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

INFINITE (2015)

INnovative laser machine For INdustrial engravIng and 3d TExturing

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More  

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More